J. Van Meerbeeck
University of Antwerp
12 Papers
148 Citations
J. Van Meerbeeck is an academic researcher from University of Antwerp. The author has contributed to research in topics: Lung cancer & Mesothelium. The author has an hindex of 10, co-authored 12 publications.
Chat about Author
Papers
Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group.
J. Van Meerbeeck,C. Debruyne,N. van Zandwijk,Pe Postmus,M.C. Pennucci,F.J.M. van Breukelen,D. Galdermans,H. Groen,P. Pinson,M. van Glabbeke,E. Van Marck,G. Giaccone +11 more
TL;DR: In conclusion, paclitaxel at the dose and schedule investigated in this trial had no major activity in the treatment of malignant pleural mesothelioma.
82
Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium
K. Segers,M. Ramael,Samir Kumar Singh,Joost Weyler,J. Van Meerbeeck,Paul Vermeire,E. Van Marck +6 more
TL;DR: Immunohistochemical study of bcl-2 protein immunoreactivity in human non-neoplastic mesothelium and in malignant Mesothelioma using a murine monoclonal antibody showed cytoplasmic immunore activity for bcl -2 protein in five cases of malignant mesotelioma.
45
Epidemiology of interstitial lung disease (ILD) in flanders: registration by pneumologists in 1992-1994. Working group on ILD, VRGT. Vereniging voor Respiratoire Gezondheidszorg en Tuberculosebestrijding.
M. Roelandt,Maurits Demedts,W. Callebaut,D. Coolen,Hans Slabbynck,J. Bockaert,J. Kips,J. Brie,M. Ulburghs,K. De Boeck,L. Simons,J. Van Meerbeeck,K. Vandeurzen,M. Uydebrouck +13 more
TL;DR: The overall male-female ratio was nearly one, with, however, a male preponderance in hypersensitivity pneumonitis (22/12), UIP (8/3) and "undefined fibrosis" (14/7).
44
Immunoreactivity for P-170 glycoprotein in malignant mesothelioma and in non-neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB-1
M. Ramael,J. Van den Bossche,Corinne Buysse,J. Van Meerbeeck,K. Segers,Paul Vermeire,E. Van Marck +6 more
TL;DR: The majority of malignant mesothelioma cases exhibited cytoplasmic and membrane immunore activity in neoplastic cells, which is highly significant when compared with the absence of immunoreactivity in normal mesot Helium.
26
Patterns of care for non‐small cell lung cancer patients in Belgium: A population‐based study
Leen Verleye,C. De Gendt,F. Vrijens,Viki Schillemans,Cécile Camberlin,Geert Silversmit,Sabine Stordeur,E. Van Eycken,Cécile Dubois,Jo Robays,Isabelle Wauters,J. Van Meerbeeck +11 more
TL;DR: Although not all NSCLC patients received treatment as ideally recommended by guidelines, these results do not necessarily represent poor quality of care as patient characteristics and preferences need to be taken into account.
19